Additrace concentrate for solution for infusion 10ml ampoules

Nazione: Regno Unito

Lingua: inglese

Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)

Principio attivo:

Sodium fluoride; Potassium iodide; Zinc chloride; Chromic chloride hexahydrate; Copper chloride dihydrate; Manganese chloride tetrahydrate; Sodium molybdate dihydrate; Sodium selenite anhydrous; Ferric chloride hexahydrate

Commercializzato da:

Fresenius Kabi Ltd

Codice ATC:

B05XA31

INN (Nome Internazionale):

Sodium fluoride; Potassium iodide; Zinc chloride; Chromic chloride hexahydrate; Copper chloride dihydrate; Manganese chloride tetrahydrate; Sodium molybdate dihydrate; Sodium selenite anhydrous; Ferric chloride hexahydrate

Dosaggio:

210microgram/1ml ; 16.6microgram/1ml ; 1.36mg/1ml ; 5.33microgram/1ml ; 340microgram/1ml ; 99microgram/1ml ; 4.85microgram/1ml ; 6.9microgram/1ml ; 540microgram/1ml

Forma farmaceutica:

Solution for infusion

Via di somministrazione:

Intravenous

Classe:

No Controlled Drug Status

Tipo di ricetta:

Never Valid To Prescribe As A VMP

Dettagli prodotto:

BNF: 09030000; GTIN: 5018750129020 5018750120027